We are live on ! Find out more
MM

MWG Management Portfolio holdings

AUM $81.3M Turnover 0%
1-Year Est. Return 2.28%
This Fund
S&P 500
This Quarter Est. Return
+60.91%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
–
AUM
$81.3M
AUM Growth
+$29.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
3.9 years
Top 10 Avg Time Held
3.9 years
Top 20 Avg Time Held
3.9 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BEAM icon
1
Beam Therapeutics
BEAM
$2.5B
$55M 67.66%
2,266,934
– –
2020 Q4
19 quarters
LYEL icon
2
Lyell Immunopharma
LYEL
$216M
$16.4M 20.13%
1,008,116
– –
2021 Q2
17 quarters
PRME icon
3
Prime Medicine
PRME
$695M
$9.9M 12.21%
1,792,210
– –
2022 Q4
11 quarters

Similar funds

MWG Management's Q3 2025 Portfolio in Review

As of Q3 2025, MWG Management held 3 positions worth $81.3M, up 57% from $51.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 0%. MWG Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MWG Management's ten largest holdings make up 100% of its $81.3M portfolio in Q3 2025.
  • MWG Management opened 0 new positions and closed 0 in Q3 2025.
  • MWG Management's portfolio value rose 57% quarter-over-quarter to $81.3M.

Based on MWG Management's 13F filing for Q3 2025, filed 12 Nov 2025.